🇺🇸 FDA
Patent

US 8227516

Compounds as histone deacetylase inhibitors

granted A61PA61P35/00

Quick answer

US patent 8227516 (Compounds as histone deacetylase inhibitors) held by 4SC DISCOVERY GMBH expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
4SC DISCOVERY GMBH
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P35/00